SML2657

MP-A08

≥98% (HPLC)

• Synonym(e): 4-Methyl-N-[2-[[[2-[[(4-methylphenyl)sulfonyl]amino]phenyl]imino]methyl]phenyl]benzenesulfonamide, NSC-122314
• Empirische Formel (Hill-System): C₂₇H₂₅N₃O₄S₂
• CAS-Nummer: 219832-49-2
• Molekulargewicht: 519.64
• MDL-Nummer: MFCD01053753
• UNSPSC-Code: 12352200
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 100
• Assay: ≥98% (HPLC)
• Form: powder
• Farbe: white to beige
• Löslichkeit: DMSO: 2 mg/mL, clear
• Lagertemp.: 2-8°C
• SMILES String: [S](=O)(=O)(Nc2c(cccc2)\N=C\c3c(cccc3)N[S](=O)(=O)c4ccc(cc4)C)c1ccc(cc1)C
• InChIKey: FLDBNMYJUMAXDQ-TURZUDJPSA-N

Beschreibung

Biochem./physiol. Wirkung

MP-A08 is a highly selective ATP-competitive sphingosine kinase inhibitor that targets both SK1 and SK2. It is more selective and acts by different mechanisms than other SK inhibitors. MP-A0 targets the ATP-binding pocket, rather than the sphingosine binding pocket, with Ki values of 6.9 and 27 μM, respectively. Also, both SKI-II and PF-543 are thought to act in part by targeting sphingosine kinase for proteasomal degradation, which is not the case with MP-A08. MP-A08 was found to suppress the growth of human lung tumor xenografts in mice, both inducing apoptosis and inhibiting angiogenesis.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable